deltatrials
Terminated NA INTERVENTIONAL 2-arm NCT02459015

Performance Study of an Artificial Nerve Guide (Reaxon® Nerve Guide) to Treat Digital Nerve Lesions

A Controlled, Randomized, Comparison, Blind Evaluation of Repair of Digital Nerve Lesions in Man Using an Implanted Reaxon® Nerve Guide

Sponsor: Medovent GmbH

Interventions Implantation
Updated 6 times since 2017 Last updated: Jun 14, 2018 Started: Jun 30, 2015 Primary completion: May 31, 2018 Completion: May 31, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The study was stopped due to slow patient recruitment and insufficient patient compliance.

Listed as NCT02459015, this NA trial focuses on Peripheral Nerve Injuries and remains terminated or withdrawn. Sponsored by Medovent GmbH, it has been updated 6 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotRecruiting~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshotRecruiting~Jul 2018 – ~Jan 2021 · 30 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated NA

  4. Jul 2018 — Jan 2021 [monthly]

    Terminated NA

    Status: RecruitingTerminated

  5. Jun 2018 — Jul 2018 [monthly]

    Recruiting NA

Show 1 earlier version
  1. Jan 2017 — Jun 2018 [monthly]

    Recruiting NA

    First recorded

Jun 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Medovent GmbH
Data source: Medovent GmbH

For direct contact, visit the study record on ClinicalTrials.gov .